J Korean Med Assoc.  2011 Nov;54(11):1179-1188.

Safe sedation in a private clinic

• Lee JW
• Lee KY

Abstract

Procedural sedation and analgesia are now becoming more frequently required and procedural safety is one of the main interests of private clinic physicians. Efforts to establish safe sedation and analgesia include patient assessment to avoid sedating patients with risk factors, training for drug administration, airway management, and treatment of adverse effects, proper preparation of monitoring and resuscitation equipments and recovery facility, thorough recording of the sedation process as well as the procedure itself, analysis of results and quality assessment. Complications during procedural sedation and analgesia, including nausea and vomiting, respiratory depression, hypoxia and even cardiac arrest, should be prevented and properly treated. In this review, basic requirements for procedural sedation and analgesia are to be described, such as sedatives/analgesics including propofol, midazolam, ketamine, etomidate and dexmedetomidine, and airway management with ventilatory support for respiratory depression. Most of all, proper education and repeated training for airway management with ventilatory support and cardiopulmonary resuscitation are critically important for all the personnel involving the procedural sedation and analgesia.

Keyword

Moderate sedation; Sedatives; Adverse effects

MeSH Terms

Airway Management
Analgesia
Anoxia
Cardiopulmonary Resuscitation
Conscious Sedation
Dexmedetomidine
Etomidate
Heart Arrest
Humans
Hypnotics and Sedatives
Ketamine
Midazolam
Nausea
Propofol
Respiratory Insufficiency
Resuscitation
Risk Factors
Vomiting
Dexmedetomidine
Etomidate
Hypnotics and Sedatives
Ketamine
Midazolam
Propofol

Reference

1. Knape JT, Adriaensen H, vanAken H, Blunnie WP, Carlsson C, Dupont M, Pasch T. Board of Anaesthesiology of the European Union of Medical Specialists. Guidelines for sedation and/or analgesia by non-anaesthesiology doctors. Eur J Anaesthesiol. 2007. 24:563–567.

2. Brown TB, Lovato LM, Parker D. Procedural sedation in the acute care setting. Am Fam Physician. 2005. 71:85–90.

3. American Society of Anesthesiologists Task Force on Sedation and Analgesia by Non-Anesthesiologists. Practice guidelines for sedation and analgesia by non-anesthesiologists. Anesthesiology. 2002. 96:1004–1017.

4. ASA physical status classification system [Internet]. cited 2011 Sep 24. Park Ridge (IL): American Society of Anesthesiologists;Available from: http://www.asahq.org/clinical/physicalstatus.htm.

5. Practice guidelines for preoperative fasting and the use of pharmacologic agents to reduce the risk of pulmonary aspiration: application to healthy patients undergoing elective procedures: a report by the American Society of Anesthesiologist Task Force on Preoperative Fasting. Anesthesiology. 1999. 90:896–905.

6. The 2011 guidelines of Korean Association of Cardiopulmonary Resuscitation for CPR [Internet]. 2011. cited 2011 Sep 28. Seoul: Korean Association of Cardiopulmonary Resuscitation;Available from: http://www.kacpr.org/popup/file/2011_guidelines.pdf.

7. Adam HK, Kay B, Douglas EJ. Blood disoprofol levels in anesthetised patients. Correlation of concentrations after single or repeated doses with hypnotic activity. Anaesthesia. 1982. 37:536–540.

8. Smith C, McEwan AI, Jhaveri R, Wilkinson M, Goodman D, Smith LR, Canada AT, Glass PS. The interaction of fentanyl on the Cp50 of propofol for loss of consciousness and skin incision. Anesthesiology. 1994. 81:820–828.

9. Mackenzie N, Grant IS. Propofol for intravenous sedation. Anaesthesia. 1987. 42:3–6.

10. Wilson E, Mackenzie N, Grant IS. A comparison of propofol and midazolam by infusion to provide sedation in patients who receive spinal anaesthesia. Anaesthesia. 1988. 43:Suppl. 91–94.

11. Beller JP, Pottecher T, Lugnier A, Mangin P, Otteni JC. Prolonged sedation with propofol in ICU patients: recovery and blood concentration changes during periodic interruptions in infusion. Br J Anaesth. 1988. 61:583–588.

12. Taylor MB, Grounds RM, Mulrooney PD, Morgan M. Ventilatory effects of propofol during induction of anaesthesia. Comparison with thiopentone. Anaesthesia. 1986. 41:816–820.

13. Goodman NW, Black AM, Carter JA. Some ventilatory effects of propofol as sole anaesthetic agent. Br J Anaesth. 1987. 59:1497–1503.

14. Jonsson MM, Lindahl SG, Eriksson LI. Effect of propofol on carotid body chemosensitivity and cholinergic chemotransduction. Anesthesiology. 2005. 102:110–116.

15. Larsen R, Rathgeber J, Bagdahn A, Lange H, Rieke H. Effects of propofol on cardiovascular dynamics and coronary blood flow in geriatric patients. A comparison with etomidate. Anaesthesia. 1988. 43:Suppl. 25–31.

16. Guidelines for safe use of propofol [Internet]. cited 2011 Sep 28. Cheongwon: Korea Food & Drug Administration, National Institute of Food and Drug Safety Evaluation;Available from: http://www.kfda.go.kr/antidrug/ebook/propofol.html.

17. Walder B, Elia N, Henzi I, Romand JR, Tramèr MR. A lack of evidence of superiority of propofol versus midazolam for sedation in mechanically ventilated critically ill patients: a qualitative and quantitative systematic review. Anesth Analg. 2001. 92:975–983.

18. Gross JB, Zebrowski ME, Carel WD, Gardner S, Smith TC. Time course of ventilatory depression after thiopental and midazolam in normal subjects and in patients with chronic obstructive pulmonary disease. Anesthesiology. 1983. 58:540–544.

19. Sunzel M, Paalzow L, Berggren L, Eriksson I. Respiratory and cardiovascular effects in relation to plasma levels of midazolam and diazepam. Br J Clin Pharmacol. 1988. 25:561–569.

20. Reves JG, Fragen RJ, Vinik HR, Greenblatt DJ. Midazolam: pharmacology and uses. Anesthesiology. 1985. 62:310–324.

21. White PF, Way WL, Trevor AJ. Ketamine--its pharmacology and therapeutic uses. Anesthesiology. 1982. 56:119–136.

22. Okamoto GU, Duperon DF, Jedrychowski JR. Clinical evaluation of the effects of ketamine sedation on pediatric dental patients. J Clin Pediatr Dent. 1992. 16:253–257.

23. Soliman MG, Brindle GF, Kuster G. Response to hypercapnia under ketamine anaesthesia. Can Anaesth Soc J. 1975. 22:486–494.

24. Corssen G, Gutierrez J, Reves JG, Huber FC Jr. Ketamine in the anesthetic management of asthmatic patients. Anesth Analg. 1972. 51:588–596.

25. Savege TM, Colvin MP, Weaver EJ, Bond C, Drake J, Inniss R. A comparison of some cardiorespiratory effects of althesin and ketamine when used for induction of anaesthesia in patients with cardiac disease. Br J Anaesth. 1976. 48:1071–1081.

26. Sussman DR. A comparative evaluation of ketamine anesthesia in children and adults. Anesthesiology. 1974. 40:459–464.

27. Fragen RJ, Caldwell N. Comparison of a new formulation of etomidate with thiopental: side effects and awakening times. Anesthesiology. 1979. 50:242–244.

28. Gooding JM, Weng JT, Smith RA, Berninger GT, Kirby RR. Cardiovascular and pulmonary responses following etomidate induction of anesthesia in patients with demonstrated cardiac disease. Anesth Analg. 1979. 58:40–41.

29. Criado A, Maseda J, Navarro E, Escarpa A, Avello F. Induction of anaesthesia with etomidate: haemodynamic study of 36 patients. Br J Anaesth. 1980. 52:803–806.

30. Wagner RL, White PF. Etomidate inhibits adrenocortical function in surgical patients. Anesthesiology. 1984. 61:647–651.

31. Bhana N, Goa KL, McClellan KJ. Dexmedetomidine. Drugs. 2000. 59:263–268.

32. Precedex (dexmedetomidine hydrochloride) injection: prescribing information [Internet]. 2010. cited 2011 Sep 29. Lake Forest (IL): Hospira Inc;Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021038s017lbl.pdf.

33. Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology. 2000. 93:382–394.

34. Hsu YW, Cortinez LI, Robertson KM, Keifer JC, Sum-Ping ST, Moretti EW, Young CC, Wright DR, Macleod DB, Somma J. Dexmedetomidine pharmacodynamics. Part I: crossover comparison of the respiratory effects of dexmedetomidine and remifentanil in healthy volunteers. Anesthesiology. 2004. 101:1066–1076.

35. Bloor BC, Ward DS, Belleville JP, Maze M. Effects of intravenous dexmedetomidine in humans II Hemodynamic changes. Anesthesiology. 1992. 77:1134–1142.

36. Apan A, Doganci N, Ergan A, Buyukkocak U. Bispectral index-guided intraoperative sedation with dexmedetomidine and midazolam infusion in outpatient cataract surgery. Minerva Anestesiol. 2009. 75:239–244.

37. Drummond JC, Dao AV, Roth DM, Cheng CR, Atwater BI, Minokadeh A, Pasco LC, Patel PM. Effect of dexmedetomidine on cerebral blood flow velocity, cerebral metabolic rate, and carbon dioxide response in normal humans. Anesthesiology. 2008. 108:225–232.

38. Venn RM, Bryant A, Hall GM, Grounds RM. Effects of dexmedetomidine on adrenocortical function, and the cardiovascular, endocrine and inflammatory responses in postoperative patients needing sedation in the intensive care unit. Br J Anaesth. 2001. 86:650–656.

39. Iirola T, Vilo S, Aantaa R, Wendelin-Saarenhovi M, Neuvonen PJ, Scheinin M, Olkkola KT. Dexmedetomidine inhibits gastric emptying and oro-caecal transit in healthy volunteers. Br J Anaesth. 2011. 106:522–527.

40. Abdalla MI, Al Mansouri F, Bener A. Dexmedetomidine during local anesthesia. J Anesth. 2006. 20:54–56.

41. Hoy SM, Keating GM. Dexmedetomidine: a review of its use for sedation in mechanically ventilated patients in an intensive care setting and for procedural sedation. Drugs. 2011. 71:1481–1501.